COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,001 | +4.0% | 358 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,693 | -10.4% | 358 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $8,588 | +35.6% | 358 | +31.1% | 0.01% | +25.0% |
| Q4 2022 | $6,334 | +26.7% | 273 | -20.4% | 0.00% | +33.3% |
| Q3 2022 | $5,000 | -16.7% | 343 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $6,000 | +50.0% | 343 | +61.8% | 0.00% | +100.0% |
| Q4 2021 | $4,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -20.0% | 212 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $5,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +25.0% | 212 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | 0.0% | 238 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $4,000 | -20.0% | 238 | -42.1% | 0.00% | +33.3% |
| Q3 2019 | $5,000 | -16.7% | 411 | -8.3% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -14.3% | 448 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $7,000 | 0.0% | 448 | -3.9% | 0.01% | +66.7% |
| Q3 2018 | $7,000 | – | 466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |